Crossmark

A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

Crossref DOI link: https://doi.org/10.1186/s42077-020-00098-3

Published Online: 2020-10-07

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

El Fawy, Dalia M.

Ibrahim, Azza Yousef

Abdulmageed, Ahmed Mostafa Mohamed https://orcid.org/0000-0002-0591-7147
El Seddek, Eman Abo Bakr
License Information

Text and Data Mining valid from 2020-10-07

Version of Record valid from 2020-10-07
More Information

Article History

Received: 31 July 2020

Accepted: 23 September 2020

First Online: 7 October 2020

Ethics approval and consent to participate

: Approval of the research ethical committee of Faculty of Medicine, Ain-Shams University, was obtained (code number: FMASU MD 84/2018), and written informed consent was obtained from patients’ legal guardian(s) after the description of the procedure and its potential complications.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below